Stockreport

Apotex Strengthens Commitment to Women's Health with Exclusive Canadian Rights to "Linzagolix" for Uterine Fibroid Treatment [Yahoo! Finance]

JAPAN EXCH GRP UNSP/ADR  (JPXGY) 
NASDAQ:AMEX Investor Relations: jpx.co.jp/english/corporate/investor-relations
PDF announced it has entered into a strategic licensing agreement securing exclusive Canadian rights to linzagolix, a once-daily oral treatment developed by Kissei Pharmaceu [Read more]